gyki 52466 and nitroarginine

gyki 52466 has been researched along with nitroarginine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Czuczwar, SJ; Kleinrok, Z; Olszewski, K; Tutka, P; Wielosz, M; Woźniak, M	1

Other Studies

1 other study(ies) available for gyki 52466 and nitroarginine

Article	Year
Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:4 Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Dizocilpine Maleate; Drug Synergism; Electroshock; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Mice; Molsidomine; Motor Activity; Nitric Oxide Synthase; Nitroarginine; Receptors, Glutamate; Riluzole	2002

Article

Year

Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:4

Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Dizocilpine Maleate; Drug Synergism; Electroshock; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Mice; Molsidomine; Motor Activity; Nitric Oxide Synthase; Nitroarginine; Receptors, Glutamate; Riluzole

2002